The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.